AVENTURA, Fla., Jan. 6, 2012 /PRNewswire/ -- Fuse Science Inc. (OTCQB: DROP) (www.fusescience.com), announced today that its new EnerJel™ product is now available for sale on Amazon.com. The online retailer has over 60 million active customers worldwide and represents the first in a series of expanded distribution channels planned by the company.
(Logo: http://photos.prnewswire.com/prnh/20110615/CL20255LOGO )
Fuse Science launched its first product EnerJel™ in a series of 4 on December 30, 2011 online at www.poweredbyfuse.com. The overwhelming interest in Fuse Science and the product launch forced the company to increase server capacity ahead of schedule in order to handle spikes in traffic. These actions were completed in real time without issue and positions the company's accelerated growth. Inherent in this strategy is the continued advancement of its global distribution strategy that began online and will move to targeted global retail locations in 2012.
Such demand was created as Fuse Science has made significant inroads within the athletic community and was able to secure endorsers to include Tiger Woods, David "Big Papi" Ortiz, and Arian Foster. FUSE Science made major headway this week as Tim Grover (trainer to the NBA elite) endorsed EnerJel™ and said, "I am partnering with Fuse Science and sharing this technology with some of the best athletes in the world to help them improve their nutrition and natural performance."
About Fuse Science Inc.
Fuse Science Inc. (OTCQB: DROP) formerly known as Double Eagle Holdings Ltd., is an innovative consumer products holding company based in Aventura , Florida. Fuse Science is the developer of new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The company has successfully developed and maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science is available online at www.fusescience.com or by calling 305-503-FUSE (3873).
Safe Harbor Statement: Certain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.
SOURCE Fuse Science Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article